Interestingly, HBX can activate NF-κB through a variety of distinct signaling pathways involving PI3-K (153, 154), and ERK (155), contributing to the regulation of motility and inflammatory responses in HCC cells. Here, NFKB1 is linked to hepatocellular carcinoma.